Image-guided therapy developer ViewRay has received the CE Mark for its MRIdian MRI-guided radiation therapy device.
MRIdian is now the only MRI-guided radiation therapy device approved to treat patients in Europe, according to the vendor. The MRIdian system received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in May 2012 and the first patients were treated in January 2014 at Washington University in St. Louis, Missouri.
